Brief: Maxcyte Signs Platform License Agreement With Adicet Bio
04/08/2025 13:52
Aug 4 (Reuters) - MaxCyte Inc MXCT.O: MAXCYTE SIGNS PLATFORM LICENSE AGREEMENT WITH ADICET BIO MAXCYTE INC - ADICET BIO OBTAINS RIGHTS TO USE MAXCYTE'S TECHNOLOGY Source text: ID:nGNXbxV8JV Further company coverage: MXCT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MaxCyte
See all newsMaxCyte Q1 revenue falls
Brief: Maxcyte Appoints Parmeet Ahuja As Chief Financial Officer
Brief: Maxcyte Announces Preliminary Unaudited Fourth Quarter And Full Year 2025 Financial Results
MaxCyte Q3 revenue falls 16% hurt by lower sales in instruments
Brief: MaxCyte Announces Planned CFO Transition In 2026